NEOG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While NEOG seems to be doing ok healthwise, there are quite some concerns on its profitability. NEOG is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year NEOG was profitable.
In the past year NEOG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NEOG reported negative net income in multiple years.
Each year in the past 5 years NEOG had a positive operating cash flow.

1.2 Ratios

NEOG has a Return On Assets (-17.94%) which is comparable to the rest of the industry.
With a Return On Equity value of -28.64%, NEOG perfoms like the industry average, outperforming 56.45% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-17.94%
ROE	-28.64%
ROIC	N/A

ROA(3y)-10.81%

ROA(5y)-4.19%

ROE(3y)-17.92%

ROE(5y)-8.21%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of NEOG (45.98%) is worse than 60.75% of its industry peers.
NEOG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NEOG so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	45.98%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.72%

GM growth 5Y0.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NEOG remains at a similar level compared to 1 year ago.
NEOG has more shares outstanding than it did 5 years ago.
NEOG has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that NEOG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.20, NEOG is in line with its industry, outperforming 51.61% of the companies in the same industry.
NEOG has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
NEOG has a Debt to Equity ratio (0.38) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Altman-Z	1.2

ROIC/WACCN/A

WACC10.18%

2.3 Liquidity

NEOG has a Current Ratio of 3.91. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.
NEOG's Current ratio of 3.91 is fine compared to the rest of the industry. NEOG outperforms 67.74% of its industry peers.
NEOG has a Quick Ratio of 2.80. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.
NEOG's Quick ratio of 2.80 is fine compared to the rest of the industry. NEOG outperforms 63.98% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.91
Quick Ratio	2.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NEOG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.50%.
The earnings per share for NEOG have been decreasing by -10.20% on average. This is quite bad
NEOG shows a decrease in Revenue. In the last year, the revenue decreased by -3.67%.
The Revenue has been growing by 16.43% on average over the past years. This is quite good.

EPS 1Y (TTM)-27.5%

EPS 3Y-9.82%

EPS 5Y-10.2%

EPS Q2Q%-9.09%

Revenue 1Y (TTM)-3.67%

Revenue growth 3Y19.28%

Revenue growth 5Y16.43%

Sales Q2Q%-2.84%

3.2 Future

Based on estimates for the next years, NEOG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.62% on average per year.
The Revenue is expected to grow by 0.72% on average over the next years.

EPS Next Y-25.82%

EPS Next 2Y2.51%

EPS Next 3Y4.1%

EPS Next 5Y14.62%

Revenue Next Year-4.5%

Revenue Next 2Y-1.3%

Revenue Next 3Y-0.81%

Revenue Next 5Y0.72%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 33.79, NEOG can be considered very expensive at the moment.
Based on the Price/Earnings ratio, NEOG is valued a bit cheaper than 72.58% of the companies in the same industry.
When comparing the Price/Earnings ratio of NEOG to the average of the S&P500 Index (27.21), we can say NEOG is valued slightly more expensively.
NEOG is valuated quite expensively with a Price/Forward Earnings ratio of 28.26.
NEOG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NEOG is cheaper than 74.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, NEOG is valued at the same level.

		Industry Rank	Sector Rank
PE	33.79
Fwd PE	28.26

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NEOG indicates a somewhat cheap valuation: NEOG is cheaper than 70.97% of the companies listed in the same industry.